U.S. Department of Justice False Claims Act Update

You are subscribed to False Claims Act for U.S. Department of Justice. This information has recently been updated, and is now available.

BioReference Health and OPKO Health Agree to Pay $704,349 to Settle Allegations that they Billed the Government for Medically Unnecessary Blood Tests

01/17/2025 07:00 AM EST

BioReference Health LLC, formerly known as BioReference Laboratories Inc. (BioReference) and OPKO Health Inc. (OPKO), have agreed to pay $704,349 to resolve alleged violations of the False Claims Act arising from BioReference's submission of claims for laboratory tests that had not been ordered by a patient's provider. OPKO is a Delaware Corporation. BioReference, a subsidiary of OPKO, is headquartered in New Jersey and is one of the largest clinical laboratories in the United States.

---

     

---

You have received this e-mail because you have asked to be notified of changes to the U.S. Department of Justice website. GovDelivery is providing this service on behalf of the Department of Justice 950 Pennsylvania Ave., NW · Washington, DC 20530 · 202-514-2000 and may not use your subscription information for any other purposes.

Manage your Subscriptions | Department of Justice Privacy Policy  | GovDelivery Privacy Policy